Turtle Creek Wealth Advisors’s AbbVie ABBV Stock Holding History

Turtle Creek Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.18M	Buy	28,533 +6,047	+27%	+$1.3M	0.38%	62
2026 Q1	$4.89M	Buy	22,486 +1,735	+8%	+$385K	0.37%	69
2025 Q4	$4.74M	Buy	20,751 +8,559	+70%	+$1.95M	0.37%	72
2025 Q3	$2.82M	Buy	12,192 +3,043	+33%	+$620K	0.25%	85
2025 Q2	$1.7M	Buy	+9,149	New	+$1.7M	0.2%	94
2024 Q4	–	Sell	-2,940	Closed	-$581K	–	76
2024 Q3	$581K	Buy	2,940 +618	+27%	+$115K	0.12%	93
2024 Q2	$398K	Buy	2,322 +399	+21%	+$66.1K	0.09%	103
2024 Q1	$350K	Sell	1,923 -29	-1%	-$5K	0.09%	107
2023 Q4	$303K	Buy	+1,952	New	+$285K	0.09%	117

Other funds holding ABBV

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Turtle Creek Wealth Advisors's ABBV Position: Q2 2026 in Review

Turtle Creek Wealth Advisors increased its AbbVie (ABBV) stake by 27% in Q2 2026, buying an estimated $1.3M and bringing the position to 28,533 shares worth $7.18M. The position accounts for 0.38% of the portfolio, ranked #62.

Turtle Creek Wealth Advisors first reported a position in ABBV in Q4 2023 and has held it in 9 quarters since. 2,242 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Turtle Creek Wealth Advisors held 28,533 shares of AbbVie worth $7.18M as of Q2 2026.
Turtle Creek Wealth Advisors bought 6,047 AbbVie shares in Q2 2026, an estimated $1.3M.
AbbVie made up 0.38% of Turtle Creek Wealth Advisors's portfolio in Q2 2026, its #62 holding.
Turtle Creek Wealth Advisors first reported a position in AbbVie in Q4 2023 and has held it in 9 quarters since.
2,242 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Turtle Creek Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.